ZNF792
gene geneOn this page
Also known as FLJ38451
Summary
ZNF792 (zinc finger protein 792, HGNC:24751) is a protein-coding gene on chromosome 19q13.11, encoding Zinc finger protein 792 (Q3KQV3). May be involved in transcriptional regulation.
Enables identical protein binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 126375 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 116 total
- MANE Select transcript:
NM_175872
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24751 |
| Approved symbol | ZNF792 |
| Name | zinc finger protein 792 |
| Location | 19q13.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ38451 |
| Ensembl gene | ENSG00000180884 |
| Ensembl biotype | protein_coding |
| Entrez | 126375 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000404801, ENST00000605484, ENST00000886076
RefSeq mRNA: 1 — MANE Select: NM_175872
NM_175872
CCDS: CCDS12440
Canonical transcript exons
ENST00000404801 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001280059 | 34956354 | 34959571 |
| ENSE00002281843 | 34960235 | 34960357 |
| ENSE00002300045 | 34963630 | 34964229 |
| ENSE00002446473 | 34960868 | 34960994 |
Expression profiles
Bgee: expression breadth ubiquitous, 179 present calls, max score 81.94.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.5362 / max 37.7626, expressed in 1139 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 180463 | 1.5016 | 840 |
| 180464 | 0.7818 | 444 |
| 180462 | 0.2529 | 121 |
Top tissues by expression
245 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.94 | gold quality |
| granulocyte | CL:0000094 | 73.41 | gold quality |
| right lung | UBERON:0002167 | 73.29 | gold quality |
| islet of Langerhans | UBERON:0000006 | 72.94 | gold quality |
| leukocyte | CL:0000738 | 72.76 | gold quality |
| monocyte | CL:0000576 | 72.26 | gold quality |
| cortical plate | UBERON:0005343 | 71.97 | gold quality |
| stromal cell of endometrium | CL:0002255 | 71.93 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 71.42 | gold quality |
| ganglionic eminence | UBERON:0004023 | 71.27 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 71.21 | gold quality |
| visceral pleura | UBERON:0002401 | 71.14 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 70.99 | gold quality |
| parietal pleura | UBERON:0002400 | 70.80 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 70.65 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 70.38 | gold quality |
| lymph node | UBERON:0000029 | 70.18 | gold quality |
| upper lobe of lung | UBERON:0008948 | 70.18 | gold quality |
| ventricular zone | UBERON:0003053 | 69.97 | gold quality |
| lung | UBERON:0002048 | 69.93 | gold quality |
| apex of heart | UBERON:0002098 | 69.49 | gold quality |
| omental fat pad | UBERON:0010414 | 68.48 | gold quality |
| peritoneum | UBERON:0002358 | 68.40 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 68.05 | gold quality |
| rectum | UBERON:0001052 | 68.03 | gold quality |
| adipose tissue | UBERON:0001013 | 67.82 | gold quality |
| spleen | UBERON:0002106 | 67.81 | gold quality |
| vermiform appendix | UBERON:0001154 | 67.61 | gold quality |
| pancreas | UBERON:0001264 | 66.83 | gold quality |
| bone marrow cell | CL:0002092 | 66.70 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.45 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
108 targeting ZNF792, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-3134 | 100.00 | 66.43 | 777 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-LET-7D-5P | 99.96 | 71.76 | 1632 |
| HSA-MIR-2110 | 99.96 | 66.68 | 1930 |
| HSA-MIR-4458 | 99.96 | 71.64 | 1650 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-128-3P | 99.95 | 71.17 | 2484 |
| HSA-MIR-216A-3P | 99.95 | 71.19 | 2505 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AP-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548AQ-5P | 99.94 | 71.34 | 3426 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
| HSA-MIR-548AS-5P | 99.94 | 71.22 | 3482 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zfx | ENSDARG00000074453 |
| danio_rerio | ENSDARG00000098424 | |
| mus_musculus | Zfy2 | ENSMUSG00000000103 |
| mus_musculus | Zfy1 | ENSMUSG00000053211 |
| rattus_norvegicus | Zfy1 | ENSRNOG00000053042 |
Paralogs (38): ZFX (ENSG00000005889), ZBTB11 (ENSG00000066422), ZFAT (ENSG00000066827), ZFY (ENSG00000067646), ZNF586 (ENSG00000083828), IKZF5 (ENSG00000095574), ZNF419 (ENSG00000105136), ZNF549 (ENSG00000121406), ZSCAN20 (ENSG00000121903), ZNF304 (ENSG00000131845), PRDM15 (ENSG00000141956), ZNF660 (ENSG00000144792), ZNF711 (ENSG00000147180), ZNF773 (ENSG00000152439), ZNF256 (ENSG00000152454), ZNF837 (ENSG00000152475), ZNF691 (ENSG00000164011), ZNF610 (ENSG00000167554), E4F1 (ENSG00000167967), ZNF562 (ENSG00000171466), ZNF561 (ENSG00000171469), ZNF584 (ENSG00000171574), ZIK1 (ENSG00000171649), ZNF570 (ENSG00000171827), ZSCAN2 (ENSG00000176371), ZNF552 (ENSG00000178935), ZNF154 (ENSG00000179909), ZNF793 (ENSG00000188227), ZNF548 (ENSG00000188785), ZNF79 (ENSG00000196152), ZNF418 (ENSG00000196724), ZNF772 (ENSG00000197128), ZNF583 (ENSG00000198440), ZNF480 (ENSG00000198464), ZNF551 (ENSG00000204519), ZNF134 (ENSG00000213762), ZNF587B (ENSG00000269343), ZNF8 (ENSG00000278129)
Protein
Protein identifiers
Zinc finger protein 792 — Q3KQV3 (reviewed: Q3KQV3)
All UniProt accessions (2): Q3KQV3, S4R3B8
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_787068* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050636 | C2H2-ZF_domain-containing | Family |
Pfam: PF00096, PF01352
UniProt features (19 total): zinc finger region 13, sequence variant 2, chain 1, domain 1, modified residue 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q3KQV3-F1 | 64.47 | 0.16 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 196
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 63 (showing top):
HNF4_01, AACTTT_UNKNOWN, HNF4ALPHA_Q6, VECCHI_GASTRIC_CANCER_EARLY_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, ZWANG_DOWN_BY_2ND_EGF_PULSE, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, LMTK3_TARGET_GENES, RLF_TARGET_GENES, TAFAZZIN_TARGET_GENES, ZFP91_TARGET_GENES, ZNF2_TARGET_GENES, ZNF223_TARGET_GENES, ZSCAN31_TARGET_GENES, MIR559
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), identical protein binding (GO:0042802), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| protein binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
280 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF792 | RPP38 | P78345 | 401 |
| ZNF792 | LRIF1 | Q5T3J3 | 385 |
| ZNF792 | PRSS33 | Q8NF86 | 340 |
| ZNF792 | KAZN | Q674X7 | 330 |
| ZNF792 | LSM11 | P83369 | 327 |
| ZNF792 | ZNF277 | Q9NRM2 | 324 |
| ZNF792 | CDCA4 | Q9BXL8 | 311 |
| ZNF792 | MAST4 | O15021 | 309 |
| ZNF792 | NABP1 | Q96AH0 | 309 |
| ZNF792 | ZNF207 | O43670 | 297 |
| ZNF792 | MIER3 | Q7Z3K6 | 294 |
| ZNF792 | SH3TC2 | Q8TF17 | 294 |
| ZNF792 | ZFHX2 | Q9C0A1 | 285 |
| ZNF792 | PRDM11 | Q9NQV5 | 270 |
| ZNF792 | ARID3B | Q8IVW6 | 269 |
IntAct
173 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KRTAP10-9 | ZNF792 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF408 | ZNF792 | psi-mi:“MI:0915”(physical association) | 0.720 |
| MID2 | ZNF792 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF792 | KRTAP10-9 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF792 | ZNF408 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF792 | MID2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF792 | ZNF473 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ZNF792 | ZNF792 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ZNF473 | ZNF792 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ZNF792 | KRTAP10-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-7 | ZNF792 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HNRNPK | ZNF792 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT40 | ZNF792 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF792 | SSX2IP | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF792 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| KRTAP10-5 | ZNF792 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF792 | KRTAP10-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF792 | KRT40 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (66): ZNF792 (Two-hybrid), ZNF792 (Two-hybrid), ZNF792 (Two-hybrid), ZNF792 (Two-hybrid), ZNF792 (Two-hybrid), ZNF792 (Two-hybrid), ZNF792 (Two-hybrid), KRTAP10-7 (Two-hybrid), KRTAP10-9 (Two-hybrid), KRTAP10-5 (Two-hybrid), KRTAP10-3 (Two-hybrid), ZNF792 (Affinity Capture-RNA), ZNF792 (Affinity Capture-RNA), ZNF792 (Two-hybrid), ZNF792 (Two-hybrid)
ESM2 similar proteins: A0JNB1, A1YF12, A1YG88, A2T759, A6QLU5, B2RUI1, D3ZVT0, O14709, O43296, O75123, P10072, P15621, P17020, P17097, P51814, P85977, Q08ER8, Q0VGE8, Q14590, Q32KN0, Q3KQV3, Q4V8A8, Q5CZA5, Q5RBX0, Q5RCD9, Q5VIY5, Q61116, Q61967, Q6GQR8, Q6P9A3, Q6ZMS4, Q7TSH9, Q7TSI0, Q7Z3I7, Q86UD4, Q86WZ6, Q8BFS8, Q8IZ26, Q8N9F8, Q8TAF7
Diamond homologs: A0JPL0, A2VDP4, A3KN32, A6NFI3, A6NM28, A6QLU5, B2RXC5, B4DU55, O43296, O60765, O75290, O75467, P10072, P15622, P17014, P17023, P17030, P17031, P17032, P17098, P21506, P51508, P51523, P52736, P52738, Q02975, Q06730, Q06732, Q14590, Q14929, Q16587, Q29RZ4, Q2TL60, Q3KNS6, Q3KQV3, Q49AA0, Q4R8H9, Q4V8A8, Q4V8E9, Q5FWF6
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 50 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 7 | 14.4× | 3e-05 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
116 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 101 |
| Likely benign | 10 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
693 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:34960866:AC:A | donor_gain | 1.0000 |
| 19:34960867:CC:C | donor_gain | 1.0000 |
| 19:34960867:CCCAG:C | donor_gain | 1.0000 |
| 19:34959572:CT:C | acceptor_loss | 0.9900 |
| 19:34960862:CCTT:C | donor_loss | 0.9900 |
| 19:34960863:CTT:C | donor_loss | 0.9900 |
| 19:34960864:TTA:T | donor_loss | 0.9900 |
| 19:34960865:TACCC:T | donor_loss | 0.9900 |
| 19:34960866:A:AC | donor_gain | 0.9900 |
| 19:34960867:C:A | donor_loss | 0.9900 |
| 19:34960867:C:CC | donor_gain | 0.9900 |
| 19:34960998:CCA:C | acceptor_gain | 0.9900 |
| 19:34960999:C:T | acceptor_gain | 0.9900 |
| 19:34960999:CATGA:C | acceptor_gain | 0.9900 |
| 19:34961000:A:C | acceptor_gain | 0.9900 |
| 19:34961003:A:AC | acceptor_gain | 0.9900 |
| 19:34963625:CTCA:C | donor_loss | 0.9900 |
| 19:34963626:TCAC:T | donor_loss | 0.9900 |
| 19:34963627:CACC:C | donor_loss | 0.9900 |
| 19:34963629:C:G | donor_loss | 0.9900 |
| 19:34959572:C:CC | acceptor_gain | 0.9800 |
| 19:34960353:AAGTC:A | acceptor_gain | 0.9800 |
| 19:34960990:CAGCC:C | acceptor_gain | 0.9800 |
| 19:34960993:CC:C | acceptor_gain | 0.9800 |
| 19:34960994:CC:C | acceptor_gain | 0.9800 |
| 19:34960995:C:CA | acceptor_loss | 0.9800 |
| 19:34960995:C:CC | acceptor_gain | 0.9800 |
| 19:34961000:A:AC | acceptor_gain | 0.9800 |
| 19:34961003:A:C | acceptor_gain | 0.9800 |
| 19:34963628:A:AC | donor_gain | 0.9800 |
AlphaMissense
4258 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:34958226:G:C | F543L | 0.999 |
| 19:34958226:G:T | F543L | 0.999 |
| 19:34958228:A:G | F543L | 0.999 |
| 19:34958394:A:C | F487L | 0.999 |
| 19:34958394:A:T | F487L | 0.999 |
| 19:34958396:A:G | F487L | 0.999 |
| 19:34958478:G:C | F459L | 0.999 |
| 19:34958478:G:T | F459L | 0.999 |
| 19:34958480:A:G | F459L | 0.999 |
| 19:34958142:G:C | F571L | 0.998 |
| 19:34958142:G:T | F571L | 0.998 |
| 19:34958144:A:G | F571L | 0.998 |
| 19:34958283:G:C | H524Q | 0.998 |
| 19:34958283:G:T | H524Q | 0.998 |
| 19:34958285:G:C | H524D | 0.998 |
| 19:34958310:A:C | F515L | 0.998 |
| 19:34958310:A:T | F515L | 0.998 |
| 19:34958312:A:G | F515L | 0.998 |
| 19:34958369:G:C | H496D | 0.998 |
| 19:34958199:G:C | H552Q | 0.997 |
| 19:34958199:G:T | H552Q | 0.997 |
| 19:34958209:A:G | L549P | 0.997 |
| 19:34958227:A:G | F543S | 0.997 |
| 19:34958285:G:T | H524N | 0.997 |
| 19:34958293:A:G | L521P | 0.997 |
| 19:34958367:A:C | H496Q | 0.997 |
| 19:34958367:A:T | H496Q | 0.997 |
| 19:34958377:A:G | L493P | 0.997 |
| 19:34958446:C:G | R470P | 0.997 |
| 19:34958451:A:C | H468Q | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000110588 (19:34962156 G>A), RS1000544584 (19:34961873 T>C), RS1000877421 (19:34959998 C>T), RS1001200612 (19:34958999 T>A), RS1001211933 (19:34958773 G>A,T), RS1001213788 (19:34961179 C>T), RS1001701327 (19:34964374 C>A,T), RS1002044839 (19:34963248 G>T), RS1002111151 (19:34964213 G>A), RS1002438268 (19:34963448 T>C), RS1003207882 (19:34956662 C>T), RS1003238878 (19:34956251 C>A,T), RS1003553482 (19:34959956 G>A), RS1003707704 (19:34962028 G>A), RS1003976506 (19:34956696 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006993_14 | Hippocampal volume in Alzheimer’s disease dementia | 6.000000e-07 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005035 | hippocampal volume |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
29 total (human), top 29 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cisplatin | affects expression, affects cotreatment, increases expression | 2 |
| Cyclosporine | decreases expression, increases methylation | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| zinc chromate | increases abundance, increases expression | 1 |
| microcystin RR | increases expression | 1 |
| chromium hexavalent ion | increases abundance, increases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| abrine | decreases expression | 1 |
| licochalcone B | decreases expression | 1 |
| jinfukang | increases expression, affects cotreatment | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Temozolomide | increases expression | 1 |
| Decitabine | affects expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Doxorubicin | increases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | affects expression | 1 |
| Tunicamycin | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | decreases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Thapsigargin | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW88 | HEK293 eGFP-ZNF792 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.